Compare CRL & DY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | DY |
|---|---|---|
| Founded | 1947 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.3B |
| IPO Year | 1999 | 1995 |
| Metric | CRL | DY |
|---|---|---|
| Price | $231.56 | $430.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | $198.27 | ★ $425.30 |
| AVG Volume (30 Days) | ★ 830.5K | 516.4K |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.71 |
| EPS | N/A | ★ 3.00 |
| Revenue | ★ $1,857,601,000.00 | N/A |
| Revenue This Year | N/A | $30.96 |
| Revenue Next Year | $3.04 | $9.49 |
| P/E Ratio | ★ N/A | $145.92 |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $144.26 | $233.00 |
| 52 Week High | $236.62 | $566.47 |
| Indicator | CRL | DY |
|---|---|---|
| Relative Strength Index (RSI) | 78.36 | 40.16 |
| Support Level | $161.39 | $394.08 |
| Resistance Level | N/A | $455.17 |
| Average True Range (ATR) | 7.83 | 23.95 |
| MACD | 3.71 | -5.58 |
| Stochastic Oscillator | 89.02 | 1.63 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. The company has two reporting segments: Communications and Building Systems. The Communications segment provides specialty contracting services, including program management, planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications and digital infrastructure providers. The Building Systems segment specializes in providing comprehensive building infrastructure solutions, including electrical, energy management, security, and fire safety systems for data centers and other critical facilities. The firm generates key revenue from Communications.